NaturalNews article discussing thymus health and cancer immunotherapy outcomes.
Biotherapy
Biotherapy is a broad cancer-treatment category covering biological therapy, biologic response modifiers, immunotherapy, monoclonal antibodies, cytokines, cancer vaccines, cell therapies, oncolytic viruses, and related biologic approaches that change immune or tumor biology. Overview Biotherapy, also called biological therapy or biological response modifier therapy in older oncology literature, is a broad cancer-treatment category built around living systems and biologically derived substances.
NaturalNews article discussing concerns about secondary malignancies reported after CAR T-cell therapy.
NaturalNews article discussing dietary restriction, ketones, and possible immune effects relevant to cancer immunotherapy.
NaturalNews article describing immunotherapy, checkpoint inhibitors, CAR T-cell therapy, monoclonal antibodies, and lifestyle factors.
NaturalNews article discussing DMSO, immune-related gene effects, and its use in preserving stem cells for CAR T-cell therapy.
NaturalNews article discussing a small dostarlimab rectal cancer trial and monoclonal antibody treatment.
Review of biologic agents and biological response modifiers in cancer therapy.
SEER training page discussing biological therapy agents and the difficulty of classifying agents across chemotherapy, biologic therapy, and immunotherapy.
Mayo Clinic overview of biological therapy for cancer as treatment that helps the immune system kill cancer cells or targets cancer-cell signals.
Peer-reviewed review describing the scientific transition that allowed cancer immunotherapy to become a serious therapeutic strategy.
NCI explanation of CAR T-cell therapy as engineered immune-cell treatment for selected cancers.
Review of cytokine therapy as a cancer immunotherapy modality and its clinical research directions.
NCI overview of immunotherapy, noting that biological therapy uses substances made from living organisms to treat cancer.
SEER training page defining this treatment area as biotherapy, immunotherapy, or biological response modifier therapy.
NCI explanation of monoclonal antibodies as cancer treatments that can help the immune system recognize and destroy cancer cells.
NCI overview of targeted therapy, including monoclonal antibodies that attach to cancer-cell targets.
ACS patient overview of immunotherapy, immune recognition, biomarkers, goals, and safety considerations.
Cancer Research UK overview describing immunotherapy and noting that some immunotherapies are also called targeted treatments or biological therapies.
CRI overview explaining immunotherapy, immune checkpoint inhibitors, bispecific antibodies, adoptive cell therapies, cytokines, oncolytic viruses, and cancer vaccines.